Global DNA Repair Drugs Sales Market Report 2021

1 DNA Repair Drugs Market Overview

• 1.1 DNA Repair Drugs Product Scope
• 1.2 DNA Repair Drugs Segment by Type
  • 1.2.1 Global DNA Repair Drugs Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 PARP Inhibitors
  • 1.2.3 Other
• 1.3 DNA Repair Drugs Segment by Application
  • 1.3.1 Global DNA Repair Drugs Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Oncological
  • 1.3.3 Stroke
• 1.4 DNA Repair Drugs Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global DNA Repair Drugs Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global DNA Repair Drugs Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global DNA Repair Drugs Price Trends (2016-2027)

2 DNA Repair Drugs Estimates and Forecasts by Region

• 2.1 Global DNA Repair Drugs Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global DNA Repair Drugs Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global DNA Repair Drugs Sales Market Share by Region (2016-2021)
  • 2.2.2 Global DNA Repair Drugs Revenue Market Share by Region (2016-2021)
• 2.3 Global DNA Repair Drugs Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global DNA Repair Drugs Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global DNA Repair Drugs Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America DNA Repair Drugs Estimates and Projections (2016-2027)
  • 2.4.2 Europe DNA Repair Drugs Estimates and Projections (2016-2027)
  • 2.4.3 China DNA Repair Drugs Estimates and Projections (2016-2027)
  • 2.4.4 Japan DNA Repair Drugs Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia DNA Repair Drugs Estimates and Projections (2016-2027)
  • 2.4.6 India DNA Repair Drugs Estimates and Projections (2016-2027)

3 Global DNA Repair Drugs Competition Landscape by Players

• 3.1 Global Top DNA Repair Drugs Players by Sales (2016-2021)
• 3.2 Global Top DNA Repair Drugs Players by Revenue (2016-2021)
• 3.3 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2020)
• 3.4 Global DNA Repair Drugs Average Price by Company (2016-2021)
• 3.5 Manufacturers DNA Repair Drugs Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global DNA Repair Drugs Market Size by Type

• 4.1 Global DNA Repair Drugs Historic Market Review by Type (2016-2021)
  • 4.1.1 Global DNA Repair Drugs Sales Market Share by Type (2016-2021)
  • 4.1.2 Global DNA Repair Drugs Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global DNA Repair Drugs Price by Type (2016-2021)
• 4.2 Global DNA Repair Drugs Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global DNA Repair Drugs Sales Forecast by Type (2022-2027)
  • 4.2.2 Global DNA Repair Drugs Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global DNA Repair Drugs Price Forecast by Type (2022-2027)

5 Global DNA Repair Drugs Market Size by Application

• 5.1 Global DNA Repair Drugs Historic Market Review by Application (2016-2021)
  • 5.1.1 Global DNA Repair Drugs Sales Market Share by Application (2016-2021)
  • 5.1.2 Global DNA Repair Drugs Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global DNA Repair Drugs Price by Application (2016-2021)
• 5.2 Global DNA Repair Drugs Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global DNA Repair Drugs Sales Forecast by Application (2022-2027)
  • 5.2.2 Global DNA Repair Drugs Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global DNA Repair Drugs Price Forecast by Application (2022-2027)

6 North America DNA Repair Drugs Market Facts & Figures

• 6.1 North America DNA Repair Drugs Sales by Company
  • 6.1.1 North America DNA Repair Drugs Sales by Company (2016-2021)
  • 6.1.2 North America DNA Repair Drugs Revenue by Company (2016-2021)
• 6.2 North America DNA Repair Drugs Sales Breakdown by Type
  • 6.2.1 North America DNA Repair Drugs Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America DNA Repair Drugs Sales Breakdown by Type (2022-2027)
• 6.3 North America DNA Repair Drugs Sales Breakdown by Application
  • 6.3.1 North America DNA Repair Drugs Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America DNA Repair Drugs Sales Breakdown by Application (2022-2027)

7 Europe DNA Repair Drugs Market Facts & Figures

• 7.1 Europe DNA Repair Drugs Sales by Company
  • 7.1.1 Europe DNA Repair Drugs Sales by Company (2016-2021)
  • 7.1.2 Europe DNA Repair Drugs Revenue by Company (2016-2021)
• 7.2 Europe DNA Repair Drugs Sales Breakdown by Type
  • 7.2.1 Europe DNA Repair Drugs Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe DNA Repair Drugs Sales Breakdown by Type (2022-2027)
• 7.3 Europe DNA Repair Drugs Sales Breakdown by Application
  • 7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China DNA Repair Drugs Market Facts & Figures

• 8.1 China DNA Repair Drugs Sales by Company
  • 8.1.1 China DNA Repair Drugs Sales by Company (2016-2021)
  • 8.1.2 China DNA Repair Drugs Revenue by Company (2016-2021)
• 8.2 China DNA Repair Drugs Sales Breakdown by Type
  • 8.2.1 China DNA Repair Drugs Sales Breakdown by Type (2016-2021)
  • 8.2.2 China DNA Repair Drugs Sales Breakdown by Type (2022-2027)
• 8.3 China DNA Repair Drugs Sales Breakdown by Application
  • 8.3.1 China 166 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 166 Sales Breakdown by Application (2022-2027)

9 Japan DNA Repair Drugs Market Facts & Figures

• 9.1 Japan DNA Repair Drugs Sales by Company
  • 9.1.1 Japan DNA Repair Drugs Sales by Company (2016-2021)
  • 9.1.2 Japan DNA Repair Drugs Revenue by Company (2016-2021)
• 9.2 Japan DNA Repair Drugs Sales Breakdown by Type
  • 9.2.1 Japan DNA Repair Drugs Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan DNA Repair Drugs Sales Breakdown by Type (2022-2027)
• 9.3 Japan DNA Repair Drugs Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia DNA Repair Drugs Market Facts & Figures

• 10.1 Southeast Asia DNA Repair Drugs Sales by Company
  • 10.1.1 Southeast Asia DNA Repair Drugs Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia DNA Repair Drugs Revenue by Company (2016-2021)
• 10.2 Southeast Asia DNA Repair Drugs Sales Breakdown by Type
  • 10.2.1 Southeast Asia DNA Repair Drugs Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia DNA Repair Drugs Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia DNA Repair Drugs Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India DNA Repair Drugs Market Facts & Figures

• 11.1 India DNA Repair Drugs Sales by Company
  • 11.1.1 India DNA Repair Drugs Sales by Company (2016-2021)
  • 11.1.2 India DNA Repair Drugs Revenue by Company (2016-2021)
• 11.2 India DNA Repair Drugs Sales Breakdown by Type
  • 11.2.1 India DNA Repair Drugs Sales Breakdown by Type (2016-2021)
  • 11.2.2 India DNA Repair Drugs Sales Breakdown by Type (2022-2027)
• 11.3 India DNA Repair Drugs Sales Breakdown by Application
  • 11.3.1 India DNA Repair Drugs Sales Breakdown by Application (2016-2021)
  • 11.3.2 India DNA Repair Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in DNA Repair Drugs Business

• 12.1 4SC AG
  • 12.1.1 4SC AG Corporation Information
  • 12.1.2 4SC AG Business Overview
  • 12.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 4SC AG DNA Repair Drugs Products Offered
  • 12.1.5 4SC AG Recent Development
• 12.2 ARCAGY/ GINECO GROUP
  • 12.2.1 ARCAGY/ GINECO GROUP Corporation Information
  • 12.2.2 ARCAGY/ GINECO GROUP Business Overview
  • 12.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
  • 12.2.5 ARCAGY/ GINECO GROUP Recent Development
• 12.3 Bristol Myers Squibb
  • 12.3.1 Bristol Myers Squibb Corporation Information
  • 12.3.2 Bristol Myers Squibb Business Overview
  • 12.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
  • 12.3.5 Bristol Myers Squibb Recent Development
• 12.4 British Columbia Cancer Agency
  • 12.4.1 British Columbia Cancer Agency Corporation Information
  • 12.4.2 British Columbia Cancer Agency Business Overview
  • 12.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
  • 12.4.5 British Columbia Cancer Agency Recent Development
• 12.5 Cambridge University Hospitals NHS Foundation Trust
  • 12.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
  • 12.5.2 Cambridge University Hospitals NHS Foundation Trust Business Overview
  • 12.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
  • 12.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
• 12.6 Genentech
  • 12.6.1 Genentech Corporation Information
  • 12.6.2 Genentech Business Overview
  • 12.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Genentech DNA Repair Drugs Products Offered
  • 12.6.5 Genentech Recent Development
• 12.7 Georgetown University
  • 12.7.1 Georgetown University Corporation Information
  • 12.7.2 Georgetown University Business Overview
  • 12.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Georgetown University DNA Repair Drugs Products Offered
  • 12.7.5 Georgetown University Recent Development
• 12.8 German Breast Group
  • 12.8.1 German Breast Group Corporation Information
  • 12.8.2 German Breast Group Business Overview
  • 12.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 German Breast Group DNA Repair Drugs Products Offered
  • 12.8.5 German Breast Group Recent Development
• 12.9 GlaxoSmithKline
  • 12.9.1 GlaxoSmithKline Corporation Information
  • 12.9.2 GlaxoSmithKline Business Overview
  • 12.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
  • 12.9.5 GlaxoSmithKline Recent Development
• 12.10 Jiangsu Hengrui Medicine
  • 12.10.1 Jiangsu Hengrui Medicine Corporation Information
  • 12.10.2 Jiangsu Hengrui Medicine Business Overview
  • 12.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
  • 12.10.5 Jiangsu Hengrui Medicine Recent Development
• 12.11 Johnson & Johnson
  • 12.11.1 Johnson & Johnson Corporation Information
  • 12.11.2 Johnson & Johnson Business Overview
  • 12.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Johnson & Johnson DNA Repair Drugs Products Offered
  • 12.11.5 Johnson & Johnson Recent Development
• 12.12 Jonsson Comprehensive Cancer Center
  • 12.12.1 Jonsson Comprehensive Cancer Center Corporation Information
  • 12.12.2 Jonsson Comprehensive Cancer Center Business Overview
  • 12.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Products Offered
  • 12.12.5 Jonsson Comprehensive Cancer Center Recent Development
• 12.13 Karyopharm Therapeutics
  • 12.13.1 Karyopharm Therapeutics Corporation Information
  • 12.13.2 Karyopharm Therapeutics Business Overview
  • 12.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Karyopharm Therapeutics DNA Repair Drugs Products Offered
  • 12.13.5 Karyopharm Therapeutics Recent Development
• 12.14 KuDOS Pharmaceuticals
  • 12.14.1 KuDOS Pharmaceuticals Corporation Information
  • 12.14.2 KuDOS Pharmaceuticals Business Overview
  • 12.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Products Offered
  • 12.14.5 KuDOS Pharmaceuticals Recent Development
• 12.15 National Health Service
  • 12.15.1 National Health Service Corporation Information
  • 12.15.2 National Health Service Business Overview
  • 12.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 National Health Service DNA Repair Drugs Products Offered
  • 12.15.5 National Health Service Recent Development
• 12.16 National Institutes of Health
  • 12.16.1 National Institutes of Health Corporation Information
  • 12.16.2 National Institutes of Health Business Overview
  • 12.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 National Institutes of Health DNA Repair Drugs Products Offered
  • 12.16.5 National Institutes of Health Recent Development
• 12.17 Tesaro
  • 12.17.1 Tesaro Corporation Information
  • 12.17.2 Tesaro Business Overview
  • 12.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 Tesaro DNA Repair Drugs Products Offered
  • 12.17.5 Tesaro Recent Development

13 DNA Repair Drugs Manufacturing Cost Analysis

• 13.1 DNA Repair Drugs Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of DNA Repair Drugs
• 13.4 DNA Repair Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 DNA Repair Drugs Distributors List
• 14.3 DNA Repair Drugs Customers

15 Market Dynamics

• 15.1 DNA Repair Drugs Market Trends
• 15.2 DNA Repair Drugs Drivers
• 15.3 DNA Repair Drugs Market Challenges
• 15.4 DNA Repair Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List